February 3, 2014
Dr. Richard Furman, Division of Hematology & Medical Oncology, and co-authors have published a landmark paper in the New England Journal of Medicine. Their results utilizing the drug, Idelalisib, in a randomized, double-blinded study (5 countries) suggest that a common form of leukemia may be treated without toxic chemotherapy.